Blood coagulation analyzer: Key market research findings
- Increase in prevalence of CVDs
- Technological advances in POC procedures
- Key players include Abbott Diagnostics, Danaher, Roche Diagnostics, Siemens Healthcare, and Sysmex
Technavio has released a new report on the global blood coagulation analyzer market, which is anticipated to grow at a CAGR of around 8% between 2016 and 2020. The increase in the number of blood disorders and chronic diseases among the elderly population is primarily contributing to the growth of this market. Blood coagulation analyzers help in comprehending the composition of blood after tests. Frequent blood testing during the treatment of diseases leads to high use of blood coagulation analyzers. The America is the largest revenue generating region in the market and accounted for around 53% of the total market revenue in 2015. The major reason for this region’s growth is the increased prevalence of cardiovascular diseases (CVDs) that involves blood tests.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“The coagulation analyzers have been undergoing major changes in terms of design and function. The coagulation analyzers available these days are fully automated and can perform functions such as primary tube sampling, cap piercing, automatic rerun, and dilution. In addition, they can do sophisticated coagulation, chromogenic, and immunologic assays by using a smaller sample and reagent volume. With the growing focus on portability, accuracy, connectivity, timely results, and ease of use of the point-of-care (POC) devices, vendors will come up with innovative products during the forecast period,” saysAmber Chourasia, Lead Analyst, Lab Automation and Health and Wellness, Technavio Research.
The instruments segment will continue to dominate the market during the forecast period and is expected to account for around 59% of the total market share by 2020. Much of the segment’s growth cane be associated with the increase in the number of laboratories worldwide. Technological advances such as dual and four channel systems, which are capable of simultaneously carrying out activated partial thromboplastin time (APTT), prothrombin time (PT), FIB, and thromboplastin time (TT) are expected to boost the growth of this segment over the next four years.
The market is characterized by the presence of many diversified international and regional vendors. The key vendors dominate the market and distinguish themselves from the local players on the basis of quality, pricing, market reach, and financial resources. Competition in this market will intensify during the forecast period due to an increase in the number of laboratories worldwide and rapid technological advances related to the design, type, and method of coagulation analyzers. Several players are shifting to APAC owing to the presence of a huge patient population in the region and subsequent growth opportunities.
A more detailed analysis is available in the Technavio report, Global Blood Coagulation Analyzer Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
